Companies · Other Health Care

Twilightliving Com Inc

SEATTLE · Other Health Care

Diligence memoA one-page analyst read on Twilightliving Com Inc — recommendation, valuation, rhythm, risks.
$9.7M
Total raised · real
3
Rounds
0.7×
Latest step-up
Top 26%
Sector rank · raised
Series A
Latest stage · inferred · Thu Dec 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time)

Twilightliving Com Inc looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.32× the median modeled value of Series A Other Health Care companies in 2010–2012 (199 peers) — value vs value, same stage and era.
Dormant
  • Last raise 15.5 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Twilightliving Com Inc is one of 5377 Other Health Care companies tracked from SEATTLE. By capital raised it ranks in the upper tier (ahead of 75% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$25M$50M$75M$100MSeries A · Raised $6.0M (real) Modeled valuation $14M (est)$6.0M$14MSeries ASeed · 2010-07-16 Raised $2.2M (real) Modeled valuation $54M (est)$2.2M$54MSeed2010Seed · 2010-12-30 Raised $1.5M (real) Modeled valuation $37M (est)$1.5M$37MSeed2010+$2.2M+$1.5MCumulative $9.7M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$6.0M
Bridge · Series A-stage$2.2M · 2010smaller follow-on
Bridge · Series A-stage$1.5M · 2010smaller follow-on

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$37.2M
Base estimate est.
$1.3M
Conservative case
$291.7M
Upside case
$7.5M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series A · modeled $14.1M · Seed · modeled $54.1M · 2010-07-16Seed · modeled $37.2M · 2010-12-302010
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
38%
Survival probability
17% low · 58% high
1.54×/yr
Annual markup
2.01×/yr upside case
6.0 yr
Elapsed time used
15.5 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
246 mo
Avg between rounds
$236K/yr
Capital velocity
56.5 yr
On record since
1970
First round
3
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 4.0× above median
This company$9.7M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.3× of median
This company$1.5M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 1.7× above median
This company$37.2M
Sector median$22.1M

Raised more than 75% of sector peers (real $). Modeled value above 63% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #168 of 199.

This companyCohort peer
$10.0M$100.0M$1.0B$1.0M$10.0M$100.0MCapital raised (log)Barrx Medical Inc · Series A Raised $15.0M · modeled $302.7M (est)Icad Inc · Series A Raised $27.1M · modeled $302.7M (est)Cas Medical Systems Inc · Series A Raised $16.9M · modeled $302.7M (est)Cardiosolutions Inc · Series A Raised $18.5M · modeled $300.3M (est)Ophthonix Inc · Series A Raised $24.7M · modeled $283.4M (est)FMS Watertown, LLC · Series A Raised $13.7M · modeled $277.2M (est)Flowood Vascular Access, LLC · Series A Raised $13.7M · modeled $277.2M (est)Cardiovascular Systems Inc · Series A Raised $58.5M · modeled $272.4M (est)HemaSource Holdings LLC · Series A Raised $13.5M · modeled $272.2M (est)OMNI Home Health Acquisition, LLC · Series A Raised $12.6M · modeled $253.2M (est)Integrated Sleep Holdings Inc · Series A Raised $12.4M · modeled $249.9M (est)AngioScore Inc. · Series A Raised $12.0M · modeled $242.2M (est)Twilightliving Com Inc (this company) Raised $9.7M · modeled $37.2M (est)Twilightliving Com Inc
CompanyStageRaised · realValue · estvs peer med.
Barrx Medical IncSeries A$15.0M$302.7M2.60×
Icad IncSeries A$27.1M$302.7M2.60×
Cas Medical Systems IncSeries A$16.9M$302.7M2.60×
Cardiosolutions IncSeries A$18.5M$300.3M2.58×
Ophthonix IncSeries A$24.7M$283.4M2.44×
FMS Watertown, LLCSeries A$13.7M$277.2M2.38×
Flowood Vascular Access, LLCSeries A$13.7M$277.2M2.38×
Cardiovascular Systems IncSeries A$58.5M$272.4M2.34×
HemaSource Holdings LLCSeries A$13.5M$272.2M2.34×
OMNI Home Health Acquisition, LLCSeries A$12.6M$253.2M2.18×
Integrated Sleep Holdings IncSeries A$12.4M$249.9M2.15×
AngioScore Inc.Series A$12.0M$242.2M2.08×
Twilightliving Com Inc this companySeries A$9.7M$37.2M0.32×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$2.2M2010-07-16$10.9M$54.1M90%
Seed$1.5M2010-12-30$7.5M$37.2M90%
Series A$6.0M$27.3M$14.1M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$2.2M2010-07-16
    • First recorded raise — entered as Seed.
  2. Seed$1.5M2010-12-30
    • Came back fast: 5 mo vs the ~14 mo sector norm.
    • Round 1.5× smaller than the prior — bridge or down round.
Intelligence
2031 ~Q2
Modeled next raise · ~246mo cadence
$1.5M
Modeled next size est.range $1.5M$2.4M
0.7×
Last step-up
$236K/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Kyle Salem1 other
Steve Chambers1 other
KAY T. SEIM2010-07
KYLE T. SALEM2010-07
MALCOLM T. GLESER2010-07
MICHAEL T. CASSLING2010-12
Mike Cassling
MIKE T. CASSLING2010-07
Paul Hogan
PAUL T. HOGAN2010-07
Ross Taylor
ROSS T. TAYLOR2010-07
STEVE T. CHAMBERS2010-07
TED T. TANASE2010-07
Wayne Sensor
Registry & provenance

Twilightliving Com Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1119825
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Tele911, Inc.Other Health CareSeries A$9.7M$31.6Msame sector · same stage
Head First RCM, LLCOther Health CareSeries A$9.6M$34.3Msame sector · same stage
Responsive Arthroscopy, Inc.Other Health CareSeries A$10.0M$42.7Msame sector · same stage
Iridex CorpOther Health CareSeries A$10.0M$37.3Msame sector · same stage
Manuka Performance USA, Inc.Other Health CareSeries A$10.0M$41.6Msame sector · same stage
Protean Biodiagnostics Inc.Other Health CareSeries A$9.3M$35.4Msame sector · same stage
RazorMetrics, Inc.Other Health CareSeries A$9.1M$32.4Msame sector · same stage
Gulf Coast Canna Meds, Inc.Other Health CareSeries A$9.0M$40.4Msame sector · same stage
Frequently asked
How much funding has Twilightliving Com Inc raised?
Twilightliving Com Inc has raised approximately $9.7M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is Twilightliving Com Inc's estimated valuation?
Provath's modeled valuation for Twilightliving Com Inc is approximately $37.2M (modeled range $1.3M–$291.7M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Twilightliving Com Inc at?
Twilightliving Com Inc's latest modeled financing stage is Series A. Its most recent recorded round closed around Thu Dec 30.
What does Twilightliving Com Inc do and where is it based?
Twilightliving Com Inc operates in the Other Health Care sector, based in SEATTLE.
Explore related

See where Twilightliving Com Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Twilightliving Com Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.